Annual Securities Report — FY2025
What VITAL KSK HOLDINGS,INC. reported for the period from 2025-04-01 to 2026-03-31.
Filed 2026-06-19View the original on EDINET
How much it says
75Very detailed
What moved here
14named for the first time
Its own wording
41terms
Which filing this is
36/ 36newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the consolidated fiscal year, sales increased mainly because the Group focused on sales of products eligible for the new-drug creation premium and influenza vaccines in its pharmaceutical wholesaling business. Core operating profit declined, while net income attributable to owners of the parent increased, despite the recognition of ¥1,280 million in R&D expenses, due in part to gains on the sale of investment securities.
Komori's summary of this document, not the document's own words.75Very detailed
How much this filing saysA weighted roll-up of 12 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 39 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
76
Very detailed
91
Very detailed
100
Very detailed
75
Very detailed
40
Thin
100
Very detailed
68
Detailed
50
Typical
100
Very detailed
53
Typical
79
Very detailed
50
Typical
R&D spend13億円Money spent making new things.
Cash left over38億円Cash from the business, less what went into equipment.
Spent on equipment58億円Plants, machines — things meant to last.
Employees3,871Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.